|Articles|November 1, 2016
- Pharmaceutical Executive-11-01-2016
- Volume 36
- Issue 11
Pharmaceutical Executive, November 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Pharm Exec's 2017 Pipeline Reportalmost 10 years ago
Digital Disruption is Coming: Are You Ready?almost 10 years ago
8 Winning Commercial Portfolio Strategiesalmost 10 years ago
Building Market Access Competencies for the Futurealmost 10 years ago
Loss of Exclusivity: Strategies to Maximize Product Valuealmost 10 years ago
Flipping the Generics Map: Apotex's Jeremy Desaialmost 10 years ago
The Pipeline: Pressures from Beyondalmost 10 years ago
Has Gastein Peaked?almost 10 years ago
Country Report: SwitzerlandAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5